Create an Account
  1. Home
  2. Upcoming Events
advertisement

Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control

EBAC-accredited Satellite Symposium during ESC Congress 2025, Madrid, Spain

Live Meeting
0.75 available credits
Information
29 august, 2025
15:15 - 16:00 CEST
IFEMA MADRID
Room: DAMASCUS, Madrid, Spain
Crossing Boundaries CETP Inhibitors and the Next Frontier in Lipid Control
ENROLL
Details
Presenters

  • Overview

    Join us for the EBAC-accredited Satellite Symposium "Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control"

    For more information, please visit the ESC website.

  • Educational objectives

    The educational objectives of the symposium are to:

    • Describe current lipid-lowering goals, inclusive of the underutilization of combination therapy. 

    • Explain the value of implementing combination strategies to optimize patient outcomes, particularly in cases where higher statin intensification is not pursued. 

    • Analyze the latest evidence and emerging insights into the role of CETP inhibitors in advancing lipid management strategies.  

    • Discuss the advancements in CETP inhibitor development, exploring their potential role in shaping the future clinical landscape of lipid management.  

  • Agenda

    15:15 – 15:20     Welcome and Introduction - Pam Taub, MD – San Diego, CA, USA  

    15:20 – 15:27     Redrawing the Map: Why We Must Cross Boundaries in Lipid Management - Ulrich Laufs, MD, PhD – Leipzig, Germany   

    15:27 – 15:34     Forging the Path: Strategic Combinations to Achieve Lipid Targets - Pam Taub, MD – San Diego, CA, USA   

    15:34 – 15:41     Cracking the Code: The Biology and Mechanism of CETP Inhibition - John Kastelein, MD, PhD – Amsterdam, The Netherlands   

    15:41 – 15:51     Breaking Through: CETP Inhibitors and the Future of Lipid Therapy - Christie Ballantyne, MD – Houston, TX, USA  

    15:51 – 16:00     Charting the Future: Panel Discussion and Q&A - All faculty

  • Accreditation

    This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 45 minutes effective education time.  Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

  • Funding

    This symposium is supported by an unrestricted educational grant from Menarini.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Details
Presenters

  • Overview

    Join us for the EBAC-accredited Satellite Symposium "Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control"

    For more information, please visit the ESC website.

  • Educational objectives

    The educational objectives of the symposium are to:

    • Describe current lipid-lowering goals, inclusive of the underutilization of combination therapy. 

    • Explain the value of implementing combination strategies to optimize patient outcomes, particularly in cases where higher statin intensification is not pursued. 

    • Analyze the latest evidence and emerging insights into the role of CETP inhibitors in advancing lipid management strategies.  

    • Discuss the advancements in CETP inhibitor development, exploring their potential role in shaping the future clinical landscape of lipid management.  

  • Agenda

    15:15 – 15:20     Welcome and Introduction - Pam Taub, MD – San Diego, CA, USA  

    15:20 – 15:27     Redrawing the Map: Why We Must Cross Boundaries in Lipid Management - Ulrich Laufs, MD, PhD – Leipzig, Germany   

    15:27 – 15:34     Forging the Path: Strategic Combinations to Achieve Lipid Targets - Pam Taub, MD – San Diego, CA, USA   

    15:34 – 15:41     Cracking the Code: The Biology and Mechanism of CETP Inhibition - John Kastelein, MD, PhD – Amsterdam, The Netherlands   

    15:41 – 15:51     Breaking Through: CETP Inhibitors and the Future of Lipid Therapy - Christie Ballantyne, MD – Houston, TX, USA  

    15:51 – 16:00     Charting the Future: Panel Discussion and Q&A - All faculty

  • Accreditation

    This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 45 minutes effective education time.  Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

  • Funding

    This symposium is supported by an unrestricted educational grant from Menarini.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free